Venus Versa News Today

Venus Concept Inc. (NASDAQ:VERO – Get Free Report) was the recipient of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 7,900 shares, a drop of 63.3% from the May 15th total of 21,500 shares. Approximately 0.3% of the shares of the company are […]

Venus Concept Inc. (NASDAQ:VERO – Get Free Report) shares traded up 7.2% on Monday . The company traded as high as $0.57 and last traded at $0.57. 9,663 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 340,706 shares. The stock had previously closed at $0.53. Venus Concept […]

Venus Concept Inc. (NASDAQ:VERO – Get Free Report)’s stock price traded up 4.2% on Thursday . The stock traded as high as $0.69 and last traded at $0.69. 7,052 shares were traded during mid-day trading, a decline of 98% from the average session volume of 421,730 shares. The stock had previously closed at $0.67. Venus […]

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic tec...

Vivos (OTCMKTS:RDGL – Get Free Report) and Venus Concept (NASDAQ:VERO – Get Free Report) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Profitability This table compares Vivos and Venus Concept’s […]

TORONTO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG

Venus Concept (NASDAQ:VERO – Get Free Report) and Surmodics (NASDAQ:SRDX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations. Institutional and Insider Ownership 87.4% of Venus Concept […]

Venus Concept (NASDAQ:VERO – Get Free Report) and Surmodics (NASDAQ:SRDX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Earnings and Valuation This table compares Venus Concept […]

Operator: Please standby. Good day, ladies and gentlemen. Welcome to the Third Quarter 2023 Earnings Conference Call for Venus Concept Inc.

TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (